Cingulate Stock Performance
| CING Stock | USD 3.80 0.14 3.83% |
The firm shows a Beta (market volatility) of 0.42, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Cingulate's returns are expected to increase less than the market. However, during the bear market, the loss of holding Cingulate is expected to be smaller as well. At this point, Cingulate has a negative expected return of -0.26%. Please make sure to confirm Cingulate's maximum drawdown, as well as the relationship between the accumulation distribution and day typical price , to decide if Cingulate performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Cingulate has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in May 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more
Actual Historical Performance (%)
One Day Return 4.11 | Five Day Return 1.33 | Year To Date Return (25.49) | Ten Year Return (99.64) | All Time Return (99.64) |
Last Split Factor 1:12 | Last Split Date 2024-08-09 |
1 | Acquisition by Brams Matthew of 2748 shares of Cingulate at 4.76 subject to Rule 16b-3 | 01/17/2025 |
2 | Acquisition by Silva Raul R. of 2748 shares of Cingulate at 4.76 subject to Rule 16b-3 | 01/22/2025 |
3 | Meta Platforms To Rally Over 29 Here Are 10 Top Analyst Forecasts For Thursday | 01/30/2025 |
4 | Acquisition by Schaffer Shane J. of 90000 shares of Cingulate at 1.79 subject to Rule 16b-3 | 01/31/2025 |
5 | Acquisition by Silva Raul R. of 17630 shares of Cingulate at 4.32 subject to Rule 16b-3 | 02/18/2025 |
6 | Acquisition by Jennifer Callahan of 21140 shares of Cingulate at 4.32 subject to Rule 16b-3 | 02/20/2025 |
7 | Cingulate Reports Safety Results from Final Phase 3 Trials for Lead ADHD Asset CTx-1301 On Track to File for FDA Approval Mid-2025 | 03/04/2025 |
8 | Acquisition by Myers Laurie of 636 shares of Cingulate at 1.5715 subject to Rule 16b-3 | 03/05/2025 |
9 | Acquisition by Myers Laurie of 17630 shares of Cingulate at 4.32 subject to Rule 16b-3 | 03/06/2025 |
10 | Cingulate reports FY results | 03/26/2025 |
11 | Acquisition by Jennifer Callahan of 115 shares of Cingulate at 4.76 subject to Rule 16b-3 | 04/09/2025 |
12 | CING 2024 Financial and Operational Results | 04/10/2025 |
| Begin Period Cash Flow | 52.4 K |
Cingulate |
Cingulate Relative Risk vs. Return Landscape
If you would invest 463.00 in Cingulate on January 12, 2025 and sell it today you would lose (83.00) from holding Cingulate or give up 17.93% of portfolio value over 90 days. Cingulate is currently does not generate positive expected returns and assumes 3.1843% risk (volatility on return distribution) over the 90 days horizon. In different words, 28% of stocks are less volatile than Cingulate, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Cingulate Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cingulate's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Cingulate, and traders can use it to determine the average amount a Cingulate's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0827
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CING |
Estimated Market Risk
| 3.18 actual daily | 28 72% of assets are more volatile |
Expected Return
| -0.26 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.08 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Cingulate is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cingulate by adding Cingulate to a well-diversified portfolio.
Cingulate Fundamentals Growth
Cingulate Stock prices reflect investors' perceptions of the future prospects and financial health of Cingulate, and Cingulate fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Cingulate Stock performance.
| Return On Equity | -53.05 | ||||
| Return On Asset | -1.07 | ||||
| Current Valuation | 6.75 M | ||||
| Shares Outstanding | 3.65 M | ||||
| Price To Book | 1.86 X | ||||
| Gross Profit | (9.45 M) | ||||
| EBITDA | (15.64 M) | ||||
| Net Income | (15.55 M) | ||||
| Cash And Equivalents | 8.2 M | ||||
| Cash Per Share | 0.73 X | ||||
| Total Debt | 5.1 M | ||||
| Debt To Equity | 0.08 % | ||||
| Current Ratio | 10.94 X | ||||
| Book Value Per Share | 2.19 X | ||||
| Cash Flow From Operations | (18.45 M) | ||||
| Earnings Per Share | (10.20) X | ||||
| Market Capitalization | 13.86 M | ||||
| Total Asset | 14.86 M | ||||
| Retained Earnings | (108.49 M) | ||||
| Working Capital | 7.69 M | ||||
About Cingulate Performance
By analyzing Cingulate's fundamental ratios, stakeholders can gain valuable insights into Cingulate's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Cingulate has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Cingulate has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | (10.53) | (10.00) | |
| Return On Tangible Assets | (1.05) | (1.10) | |
| Return On Capital Employed | (1.58) | (1.66) | |
| Return On Assets | (1.05) | (1.10) | |
| Return On Equity | (2.09) | (2.19) |
Things to note about Cingulate performance evaluation
Checking the ongoing alerts about Cingulate for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Cingulate help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Cingulate generated a negative expected return over the last 90 days | |
| Cingulate has high historical volatility and very poor performance | |
| Cingulate has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (15.55 M) with loss before overhead, payroll, taxes, and interest of (9.45 M). | |
| Cingulate currently holds about 8.2 M in cash with (18.45 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.73. | |
| Latest headline from finance.yahoo.com: CING 2024 Financial and Operational Results |
- Analyzing Cingulate's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Cingulate's stock is overvalued or undervalued compared to its peers.
- Examining Cingulate's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Cingulate's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Cingulate's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Cingulate's stock. These opinions can provide insight into Cingulate's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Cingulate Stock analysis
When running Cingulate's price analysis, check to measure Cingulate's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cingulate is operating at the current time. Most of Cingulate's value examination focuses on studying past and present price action to predict the probability of Cingulate's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cingulate's price. Additionally, you may evaluate how the addition of Cingulate to your portfolios can decrease your overall portfolio volatility.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |